13,373$
-0,14%
Echtzeit-Aktienkurs Elanco Animal Health Inc.
Bid:
Ask:
Echtzeit-Chart der Elanco Animal Health Inc. Aktie
Börsenkurse Elanco Animal Health Inc.
| Tradegate | - | - | - | - | 12,828€ | -0,34% |
| Börse Stuttgart | - | - | - | - | 12,704€ | 0,32% |
| gettex | - | - | - | - | 12,823€ | 0,23% |
| Lang & Schwarz | - | - | - | - | 12,820€ | 0,23% |
| USA | - | - | - | - | 13,360$ | -0,60% |
| New York | - | - | - | - | 13,350$ | -0,37% |
| Börse Frankfurt | - | - | - | - | 12,828€ | 1,54% |
| Echtzeit USD | - | - | - | - | 13,373$ | -0,14% |
| Echtzeit Euro | - | - | - | - | 12,823€ | 0,42% |
Fundamentaldaten der Elanco Animal Health Inc. Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2023 [USD] | 4,42 Mrd. | -1,20 Mrd. | -1,23 Mrd. | -2,50 | - | - | 1,49 |
| 2022 [USD] | 4,41 Mrd. | -72,00 Mio. | -78,00 Mio. | -0,16 | - | - | 1,44 |
| 2021 [USD] | 4,77 Mrd. | -567,00 Mio. | -472,00 Mio. | -0,97 | - | - | 1,33 |
| 2020 [USD] | 3,27 Mrd. | -672,00 Mio. | -560,10 Mio. | -1,27 | - | - | 1,93 |
| 2019 [USD] | 3,07 Mrd. | 78,20 Mio. | 67,90 Mio. | 0,18 | - | 73,08 | 1,62 |
| 2018 [USD] | 3,07 Mrd. | 114,10 Mio. | 86,50 Mio. | 0,28 | - | 48,45 | 1,59 |
| 2017 [USD] | 2,89 Mrd. | -232,60 Mio. | -310,70 Mio. | -0,85 | - | - | 1,69 |
| 2016 [USD] | 2,91 Mrd. | -22,40 Mio. | -47,90 Mio. | -0,13 | - | - | 1,68 |
| 2015 [USD] | 2,91 Mrd. | -259,50 Mio. | -210,80 Mio. | -0,58 | - | - | 1,68 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der Elanco Animal Health Inc. Aktie
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing o